1. Home
  2. STRO vs MTEN Comparison

STRO vs MTEN Comparison

Compare STRO & MTEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • MTEN
  • Stock Information
  • Founded
  • STRO 2003
  • MTEN 2015
  • Country
  • STRO United States
  • MTEN China
  • Employees
  • STRO N/A
  • MTEN N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • MTEN Building Products
  • Sector
  • STRO Health Care
  • MTEN Industrials
  • Exchange
  • STRO Nasdaq
  • MTEN Nasdaq
  • Market Cap
  • STRO 77.7M
  • MTEN 71.6M
  • IPO Year
  • STRO 2018
  • MTEN 2024
  • Fundamental
  • Price
  • STRO $0.76
  • MTEN N/A
  • Analyst Decision
  • STRO Hold
  • MTEN
  • Analyst Count
  • STRO 7
  • MTEN 0
  • Target Price
  • STRO $3.97
  • MTEN N/A
  • AVG Volume (30 Days)
  • STRO 1.4M
  • MTEN 58.0K
  • Earning Date
  • STRO 08-12-2025
  • MTEN 04-30-2025
  • Dividend Yield
  • STRO N/A
  • MTEN N/A
  • EPS Growth
  • STRO N/A
  • MTEN N/A
  • EPS
  • STRO N/A
  • MTEN N/A
  • Revenue
  • STRO $66,434,000.00
  • MTEN $10,120,257.00
  • Revenue This Year
  • STRO N/A
  • MTEN N/A
  • Revenue Next Year
  • STRO N/A
  • MTEN N/A
  • P/E Ratio
  • STRO N/A
  • MTEN N/A
  • Revenue Growth
  • STRO N/A
  • MTEN 23.03
  • 52 Week Low
  • STRO $0.52
  • MTEN $1.81
  • 52 Week High
  • STRO $5.17
  • MTEN $16.60
  • Technical
  • Relative Strength Index (RSI)
  • STRO 44.92
  • MTEN N/A
  • Support Level
  • STRO $0.67
  • MTEN N/A
  • Resistance Level
  • STRO $0.79
  • MTEN N/A
  • Average True Range (ATR)
  • STRO 0.07
  • MTEN 0.00
  • MACD
  • STRO -0.01
  • MTEN 0.00
  • Stochastic Oscillator
  • STRO 34.52
  • MTEN 0.00

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

About MTEN Mingteng International Corporation Inc. Ordinary Shares

Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides a wide range of products including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in automobile, construction machinery, and other manufacturing industries.

Share on Social Networks: